Lexicon Pharmaceuticals, Inc.
Market Cap
1B
Short interest (Jul 15)
7.4%
Net Short (Jul 27 ): 0.0%
Borrow Fee
0.41%
↑ 0.4%
Available Shares
400K
↑ 116.7%
Price Chart
Company Overview
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.